Jubilant Pharmova Limited — Important, 20-03-2025: General Updates

Jubilant Pharmova Limited reports that its subsidiary, Jubilant Biosys Innovative Research Services Pte Limited, has entered into a Shareholders’ Agreement with Pierre Fabre SA, acquiring 80% equity in the newly renamed Jubilant Biosys France. The acquisition, which includes Pierre Fabre's R&D Centre in France, indicates a significant expansion into research capabilities and enhances its position in the European market. This strategic move could positively influence investor sentiment by strengthening Jubilant’s innovation potential while expanding its global footprint. The deal's successful execution reflects a solid commitment to growth and innovation in the pharmaceutical sector.